Publication | Open Access

Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models

Medicinal ChemistryPharmacological StudyBioavailable Alk InhibitorsMedicineAntitumor EfficacyPharmacological AgentAlcl Mouse ModelsPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug Discovery